Search results

Evidence-based recommendations on Xeomin (botulinum neurotoxin type A) for treating chronic sialorrhoea (excessive salivation and drooling) caused by neurological conditions in adults.

Result type

Technology appraisal guidance

Published

9 October 2019

Question Method of botulinum toxin type A injection in treating focal spasticity:- Is guided botulinum...

Result type

Research recommendation

Published

8 March 2019

This guideline covers diagnosing, assessing and managing cerebral palsy in children and young people from birth up to their 25th birthday. It aims to make sure they get the care and treatment they need for the developmental and clinical comorbidities associated with cerebral palsy, so that they can be as active and independent as possible.

Result type

NICE guideline

Published

25 January 2017

What is the long-term effectiveness of bladder wall injection with botulinum toxin type A for overactive bladder in women?...

Result type

Research recommendation

Published

21 June 2019

Awaiting development [GID-TA11505] Expected publication date: TBC

Result type

Technology appraisal guidance

Status

Awaiting development

CG148/5 Question What is the safety and efficacy of botulinum toxin compared with (a) usual care, (b) antimuscarinics and...

Result type

Research recommendation

Published

9 June 2015

Summary of the evidence on 2% topical diltiazem hydrochloride for chronic anal fissure to inform local NHS planning and decision-making

Result type

Evidence summary

Published

22 January 2013

This guideline covers diagnosing and managing Parkinson's disease in people aged 18 and over. It aims to improve care from the time of diagnosis, including monitoring and managing symptoms, providing information and support, and palliative care.

Result type

NICE guideline

Published

19 July 2017

Evidence-based recommendations on mirabegron (Betmiga) for treating overactive bladder in adults.

Result type

Technology appraisal guidance

Published

26 June 2013

NICE has a developed medtech innovation briefing on Mollii suit for spasticity .

Result type

Medtech innovation briefing

Published

28 March 2017

local spasticity clinics, moving towards physiotherapists delivering botulinum toxin injections to improve access and...

Result type

Shared learning

Last updated

22 February 2018

This guideline covers assessing and managing motor neurone disease (MND). It aims to improve care from the time of diagnosis, and covers information and support, organisation of care, managing symptoms and preparing for end of life care.

Result type

NICE guideline

Last updated

23 July 2019

This guideline covers recognising, assessing and treating social anxiety disorder (also known as ‘social phobia’) in children and young people (from school age to 17 years) and adults (aged 18 years and older). It aims to improve symptoms, educational, occupational and social functioning, and quality of life in people with social anxiety disorder.

Result type

Clinical guideline

Published

22 May 2013

Evidence-based recommendations on transcutaneous stimulation of the cervical branch of the vagus nerve to treat cluster headache and migraine in adults. This involves using a small handheld device to stimulate a nerve in the neck.

Result type

Interventional procedures guidance

Published

23 March 2016

Evidence-based recommendations on transcranial magnetic stimulation for treating and preventing migraine. This involves placing a handheld device on the scalp to deliver magnetic pulses to the head.

Result type

Interventional procedures guidance

Published

23 January 2014